Insiders who reported open-market trades in the last 12 months at the companies Rhonda Farnum files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Eli Samaha - $5.91M in TBPH purchases and sales in the last 12 months
Eran Broshy - $1.66M in TBPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Rhonda Farnum is a corporate insider, tracked as SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc. (TBPH). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Rhonda Farnum submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Rhonda Farnum been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($1.61M) across all tracked filings.
Rhonda Farnum is SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc. (TBPH). 14 SEC Form 4 filings on record going back to 2024, most recently on 25 September 2026. Most recent open-market trade: sold $113K of TBPH on 17 September 2026. Lifetime open-market sales: $1.61M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Rhonda Farnum.
InsiderAlpha's records for Rhonda Farnum go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. 13 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
